Debate about a wide scope of political issues at the federal or state level, domestic and international US policy.Impact of those policies in our quality of live.
 
HomePortalGalleryFAQSearchRegisterLog in
ENROLL AS A MEMBER TO ENJOY QUICK ACCESS TO HARD TO FIND INFO. BE THE MOST INFORMED! ENROLL TODAY, WE WANT TO HEAR YOUR VOICE!
Search
 
 

Display results as :
 
Rechercher Advanced Search
Navigation
 Portal
 Index
 Memberlist
 Profile
 FAQ
 Search
Affiliates
free forum
 


Poll
Do you think the 911 events were an inside job , with full involment of Bush cabinet over the attack to our own people?
I believe was an inside job, the evidence is out there.
81%
 81% [ 25 ]
I don't believe in conspiracy theories, but I understand some government agencies were trying to hide theirs errors.
3%
 3% [ 1 ]
Whoever believe in the Inside job theory is out of his mind.
13%
 13% [ 4 ]
I'm not informed enough to made an educated choice.
3%
 3% [ 1 ]
Total Votes : 31
Who is online?
In total there is 1 user online :: 0 Registered, 0 Hidden and 1 Guest

None

Most users ever online was 53 on Thu Dec 19, 2013 10:48 pm
Place your ad here

Share | 
 

 Another NWO vaccination derail: U.S. advisers decline to push Gardasil for boys

View previous topic View next topic Go down 
AuthorMessage
Admin
Admin
avatar

Posts : 127
Join date : 2009-08-18
Location : Tampa,Fl

PostSubject: Another NWO vaccination derail: U.S. advisers decline to push Gardasil for boys   Thu Oct 22, 2009 2:47 am

By Maggie Fox, Health and Science Editor
WASHINGTON (Reuters) - U.S. vaccine advisers declined to press for the use of Merck & Co's Gardasil in boys and men, opting instead on Wednesday to simply advise doctors they are free to use it.
Despite some impassioned pleas from patients and doctors alike, the Advisory Committee on Immunization Practices voted almost unanimously for "permissive" use of the vaccine for boys. It protects against the human papillomavirus, or HPV, which causes a variety of cancers and genital warts.
But the committee did recommend including Gardasil for eligible boys aged 9 to 18 in the Vaccines For Children program, a government-funded system that provides vaccines to children eligible for the state-federal Medicaid health insurance plan and other uninsured children.
Merck's shares were down 1.7 percent at $33.16 in afternoon trading on the New York Stock Exchange.
The U.S. Centers for Disease Control and Prevention currently recommends Gardasil for girls 11 and 12 years old and women 13 to 26 who have not been vaccinated.
Earlier this month, the U.S. Food and Drug Administration approved Gardasil for preventing genital warts in boys and men ages 9 through 26.
The main reason the vaccine was approved was to prevent cervical cancer, which kills 4,000 women a year in the United States alone. But various strains of HPV also cause disfiguring genital warts, anal and penile cancers and head and neck cancers.
"We know that the later the cancer is discovered, the lower the chance of survival is," David Hastings of the Oral Cancer Foundation told the committee, asking for a recommendation to add the vaccine to the standard schedule for boys.
However, ACIP decided only to consider its use based on its ability to prevent genital warts. There, the costs did not seem to justify using a $360 vaccine.
"They are sending a, very unfortunately in my opinion, weak message to physicians," said Dr. William Schaffner of Vanderbilt University in Tennessee and member of the National Foundation for Infectious Diseases.
But Dr. Diane Solomon of the National Cancer Institute said ACIP had an obligation for "responsible stewardship" of taxpayer money. "I think it is important to communicate to industry that we are not going to blithely indicate excessive costs," Solomon said.
Gardasil, sold as a series of three vaccines, had global sales of $1.4 billion in 2008, with an additional $865 million received through a joint venture with Sanofi-Aventis SA.
Earlier on Wednesday, the ACIP voted to recommend the use of GlaxoSmithKline Plc's rival Cervarix vaccine for routine administration among girls 11 and 12 years old.
ACIP members said they doubted many insurers would cover HPV vaccines for boys.
Merck said it was planning a rebate program before the end of the year. "The rebate program for Gardasil enables eligible privately insured 19-26 year olds whose out-of-pocket costs are over $30 to receive a rebate from Merck for up to a maximum of $130 per dose," the company said in a statement.
(Editing by Julie Steenhuysen, Andre Grenon, Gary Hill)

_________________
"The men the American people admire most extravagantly are the greatest liars; the men they detest most violently are those who try to tell them the truth."
"All truth passes through three stages. First, it is ridiculed. Second, it is violently opposed. Third, it is accepted as being self-evident."
Arthur Schopenhauer
Back to top Go down
http://capitolhillbriefing.forumotion.com
 
Another NWO vaccination derail: U.S. advisers decline to push Gardasil for boys
View previous topic View next topic Back to top 
Page 1 of 1
 Similar topics
-
» Sri Lanka Stock Market May Decline Sharply During The Last Two Days Of The Month
» T+5 Rule of SEC reason for perpetual market decline- Investors
» Sri Lanka’s August exports decline by 13.1%, first eight months trade deficit US$ 6.26 bln
» Some people say Grain and TAFL are the reasons to decline the Market?
» Lessons Learned - The 1929 Stock Market Crash

Permissions in this forum:You cannot reply to topics in this forum
Capitol Hill Inquirer :: Health Care :: The Swine Flu Vaccine-
Jump to: